Production of high-activity extrasin beta 4 derivative by gene engineering
A technology of derivatives and thymosin, which is applied in the production of recombinant protein drugs and derivatives, can solve the problems of production rate and yield not meeting industrialization requirements, high raw material purity requirements, and low product activity.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0014] 1. Construction of thymosin β4 precursor protein expression plasmid and acquisition of engineering bacteria:
[0015] First, the whole gene sequence of thymosin β4 precursor protein was amplified by whole gene synthesis:
[0016] GGA TCC CCT CGA GCT TCT GAC AAA CCC GAT ATG GCT GAG ATC GAG AAA TTC
[0017] GAT AAG TCG AAA CTG AAG AAG ACA GAG ACG CAA GAG AAA AAT CCA CTG CCT
[0018] TCC AAA GAA ACG ATT GAA CAG GAG AAG CAA GCA GGC GAA TCG TAA GTC GAC
[0019] Using the GST gene as a template, a product of about 500 bp was amplified by PCR. After sequencing plasmid cloning and gene sequencing, the designed sequence was obtained for future use.
[0020] The target fragments were digested by BamH I, EcoR I, and XhoI to recover small fragments respectively, and the plasmid PGM was digested by XhoI and EcoRI to recover large fragments, and the three target gene fragments were ligated in T4 ligase system at 18°C. The recombinant plasmid obtained by screening was named PGMTβ4....
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com